Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States , ,Nasdaq ,Akebia Therapeutics Inc ,Prnewswire Akebia Therapeutics Inc ,Ellen Snow ,Senior Vice President ,Chief Financial Officer ,Nasdaq Listing Rule ,